Reprocessed Medical Devices Market size was valued over USD 1.0 billion in 2016 and is expected to witness more than 14% CAGR from 2017 to 2024.
Sellbyville, DE -- (SBWIRE) -- 10/11/2018 -- Reprocessed Medical Devices Market size is set to exceed USD 3 billion by 2024; according to a new research report by Global Market Insights.
Rising prevalence of chronic diseases that further lead to upsurge in surgical procedures drives reprocessed medical devices market size during the forecast timeframe. The increasing demand for cost cutting procedures in healthcare in developed as well as developing countries similarly upsurges need for usage of reprocessed medical devices thereby, propelling business growth. To reprocess the devices aspects such as, lifecycle, efficacy, probable risk to patient and the components used for manufacturing are taken into consideration. Reprocessing of medical devices requires to comply with authenticated procedure that will render its suitability for usage.
The growing healthcare cost coupled with excessive prices of purchasing new medical devices creates requirement and demand for reprocessed medical devices this stimulates progress and development for reprocessing during the forecast timeframe. Moreover, the low price of reprocessed devices is foremost influence that encourages preference over new medical devices and is accountable for the increasing demand of reprocessed medical devices.
Request sample copy of this report @ https://www.gminsights.com/request-sample/detail/477
Constant corrosion of ecological surroundings owing to growing landfills can be reduced with help of reprocessed medical devices, such factors boost the industry growth in coming years. However, the major factor that hinders reprocessed medical devices market growth is related risks of surgical site infections with reprocessed devices.
Cardiovascular medical devices held maximum revenue share of the overall reprocessed medical devices market due to high prevalence of cardiovascular diseases and, associated high surgical procedures of heart. Moreover, increasing factors such as, lack of physical exercise, unhealthy eating habits upsurges risk of cardiovascular diseases thereby, offering immense scope of growth in future for reprocessed cardiac devices.
Hospitals accounted for largest revenue share due to increasing requirement for reprocessed medical devices that aid in medical waste management. In addition to huge wastage produced from the operating rooms requires reduction of medical waste and management of landfills every year, this can be achieved through reprocessing. Furthermore, high number of surgical procedures performed in hospitals propels reprocessed medical devices market growth.
U.S. held substantial revenue share owing to rising prevalence of heart disease, supportive regulatory framework, high number of medical products producers involved in the reprocessing programs. Moreover, encouraging governing policies along with established healthcare infrastructure upsurges reprocessed medical devices market growth during the forecast period. According to, Centers for Disease Control & Prevention (CDC) statistics updated in November 2017, nearly half of Americans have three risk factors of heart disease, these include high cholesterol, smoking, and high blood pressure.
China and India are anticipated to grow lucratively due to increasing investments in healthcare setup by major players along with high incidences of chronic conditions such as, cardiovascular diseases that leads to cardiac surgeries. In addition, strengthening network of distributors in developing nations stimulates reprocessed medical devices market growth.
Make Inquiry about this report @ https://www.gminsights.com/inquiry-before-buying/477
Companies operational in the reprocessed medical devices includes Stryker Sustainability, Vanguard, GE Healthcare, Vascular Solutions, SureTek Medical, Centurion Medical Products, Soma Technology, Hygia Health Services, Steril Med (Ethicon Endo-Surgery), Mediline ReNewal, Midwest Reprocessing Centre, Medtronic, ReNu Medical, Pioneer Medical Devices, Steripro Canada, and Siemens Healthcare.
Prominent players are merging their business positions by focusing on managing Regulated Medical Waste (RMW) from landfills as well as reducing costs by adopting reprocessing and thereby, increasing business revenues. Furthermore, industry players gain tremendous benefits from reprocessing programs thereby, stimulating industry growth. For instance, in 2016, Stryker's program for reprocessing assisted health systems to save approximately 299 USD million by eliminating 12.9 USD million pounds medical waste from the landfills.